1 Study Coverage 1.1 RNA Drugs Product Introduction 1.2 Market by Type 1.2.1 Global RNA Drugs Market Size Growth Rate by Type 1.2.2 siRNA 1.2.3 ASO 1.2.4 miRNA 1.2.5 Nucleic Acid Aptamers 1.3 Market by Application 1.3.1 Global RNA Drugs Market Size Growth Rate by Application 1.3.2 Cancer 1.3.3 Diabetes 1.3.4 Tuberculosis 1.3.5 Cardiovascular Diseases 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global RNA Drugs Market Size, Estimates and Forecasts 2.1.1 Global RNA Drugs Revenue 2016-2027 2.1.2 Global RNA Drugs Sales 2016-2027 2.2 Global RNA Drugs, Market Size by Region: 2016 VS 2021 VS 2027 2.3 RNA Drugs Historical Market Size by Region (2016-2021) 2.3.1 Global RNA Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global RNA Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 RNA Drugs Market Estimates and Projections by Region (2022-2027) 2.4.1 Global RNA Drugs Sales Forecast by Region (2022-2027) 2.4.2 Global RNA Drugs Revenue Forecast by Region (2022-2027) 3 Global RNA Drugs Competitor Landscape by Players 3.1 Global Top RNA Drugs Manufacturers by Sales 3.1.1 Global RNA Drugs Sales by Manufacturer (2016-2021) 3.1.2 Global RNA Drugs Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top RNA Drugs Manufacturers by Revenue 3.2.1 Key RNA Drugs Manufacturers Covered: Ranking by Revenue 3.2.2 Global RNA Drugs Revenue by Manufacturers (2016-2021) 3.2.3 Global RNA Drugs Revenue Share by Manufacturers (2016-2021) 3.2.4 Global RNA Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by RNA Drugs Revenue in 2020 3.2.6 Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global RNA Drugs Price by Manufacturers 3.4 Global RNA Drugs Manufacturing Base Distribution, Product Types 3.4.1 RNA Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers RNA Drugs Product Type 3.4.3 Date of International Manufacturers Enter into RNA Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global RNA Drugs Market Size by Type (2016-2021) 4.1.1 Global RNA Drugs Sales by Type (2016-2021) 4.1.2 Global RNA Drugs Revenue by Type (2016-2021) 4.1.3 RNA Drugs Average Selling Price (ASP) by Type (2016-2021) 4.2 Global RNA Drugs Market Size Forecast by Type (2022-2027) 4.2.1 Global RNA Drugs Sales Forecast by Type (2022-2027) 4.2.2 Global RNA Drugs Revenue Forecast by Type (2022-2027) 4.2.3 RNA Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global RNA Drugs Market Size by Application (2016-2021) 5.1.1 Global RNA Drugs Sales by Application (2016-2021) 5.1.2 Global RNA Drugs Revenue by Application (2016-2021) 5.1.3 RNA Drugs Price by Application (2016-2021) 5.2 RNA Drugs Market Size Forecast by Application (2022-2027) 5.2.1 Global RNA Drugs Sales Forecast by Application (2022-2027) 5.2.2 Global RNA Drugs Revenue Forecast by Application (2022-2027) 5.2.3 Global RNA Drugs Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States RNA Drugs Market Size YoY Growth 2016-2027 6.1.1 United States RNA Drugs Sales YoY Growth 2016-2027 6.1.2 United States RNA Drugs Revenue YoY Growth 2016-2027 6.1.3 United States RNA Drugs Market Share in Global Market 2016-2027 6.2 United States RNA Drugs Market Size by Players (International and Local Players) 6.2.1 United States Top RNA Drugs Players by Sales (2016-2021) 6.2.2 United States Top RNA Drugs Players by Revenue (2016-2021) 6.3 United States RNA Drugs Historic Market Review by Type (2016-2021) 6.3.1 United States RNA Drugs Sales Market Share by Type (2016-2021) 6.3.2 United States RNA Drugs Revenue Market Share by Type (2016-2021) 6.3.3 United States RNA Drugs Price by Type (2016-2021) 6.4 United States RNA Drugs Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States RNA Drugs Sales Forecast by Type (2022-2027) 6.4.2 United States RNA Drugs Revenue Forecast by Type (2022-2027) 6.4.3 United States RNA Drugs Price Forecast by Type (2022-2027) 6.5 United States RNA Drugs Historic Market Review by Application (2016-2021) 6.5.1 United States RNA Drugs Sales Market Share by Application (2016-2021) 6.5.2 United States RNA Drugs Revenue Market Share by Application (2016-2021) 6.5.3 United States RNA Drugs Price by Application (2016-2021) 6.6 United States RNA Drugs Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States RNA Drugs Sales Forecast by Application (2022-2027) 6.6.2 United States RNA Drugs Revenue Forecast by Application (2022-2027) 6.6.3 United States RNA Drugs Price Forecast by Application (2022-2027) 7 North America 7.1 North America RNA Drugs Market Size YoY Growth 2016-2027 7.2 North America RNA Drugs Market Facts & Figures by Country 7.2.1 North America RNA Drugs Sales by Country (2016-2021) 7.2.2 North America RNA Drugs Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific RNA Drugs Market Size YoY Growth 2016-2027 8.2 Asia Pacific RNA Drugs Market Facts & Figures by Region 8.2.1 Asia Pacific RNA Drugs Sales by Region (2016-2021) 8.2.2 Asia Pacific RNA Drugs Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe RNA Drugs Market Size YoY Growth 2016-2027 9.2 Europe RNA Drugs Market Facts & Figures by Country 9.2.1 Europe RNA Drugs Sales by Country (2016-2021) 9.2.2 Europe RNA Drugs Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America RNA Drugs Market Size YoY Growth 2016-2027 10.2 Latin America RNA Drugs Market Facts & Figures by Country 10.2.1 Latin America RNA Drugs Sales by Country (2016-2021) 10.2.2 Latin America RNA Drugs Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa RNA Drugs Market Size YoY Growth 2016-2027 11.2 Middle East and Africa RNA Drugs Market Facts & Figures by Country 11.2.1 Middle East and Africa RNA Drugs Sales by Country (2016-2021) 11.2.2 Middle East and Africa RNA Drugs Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Pfizer 12.1.1 Pfizer Corporation Information 12.1.2 Pfizer Description and Business Overview 12.1.3 Pfizer RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Pfizer RNA Drugs Products Offered 12.1.5 Pfizer Recent Development 12.2 Roche 12.2.1 Roche Corporation Information 12.2.2 Roche Description and Business Overview 12.2.3 Roche RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Roche RNA Drugs Products Offered 12.2.5 Roche Recent Development 12.3 Sanofi-Aventis 12.3.1 Sanofi-Aventis Corporation Information 12.3.2 Sanofi-Aventis Description and Business Overview 12.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Sanofi-Aventis RNA Drugs Products Offered 12.3.5 Sanofi-Aventis Recent Development 12.4 Abbott Laboratories 12.4.1 Abbott Laboratories Corporation Information 12.4.2 Abbott Laboratories Description and Business Overview 12.4.3 Abbott Laboratories RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Abbott Laboratories RNA Drugs Products Offered 12.4.5 Abbott Laboratories Recent Development 12.5 Arrowhead Pharmaceuticals 12.5.1 Arrowhead Pharmaceuticals Corporation Information 12.5.2 Arrowhead Pharmaceuticals Description and Business Overview 12.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Arrowhead Pharmaceuticals RNA Drugs Products Offered 12.5.5 Arrowhead Pharmaceuticals Recent Development 12.6 Benitec Biopharma 12.6.1 Benitec Biopharma Corporation Information 12.6.2 Benitec Biopharma Description and Business Overview 12.6.3 Benitec Biopharma RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Benitec Biopharma RNA Drugs Products Offered 12.6.5 Benitec Biopharma Recent Development 12.7 Calimmune Inc 12.7.1 Calimmune Inc Corporation Information 12.7.2 Calimmune Inc Description and Business Overview 12.7.3 Calimmune Inc RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Calimmune Inc RNA Drugs Products Offered 12.7.5 Calimmune Inc Recent Development 12.8 Dicerna 12.8.1 Dicerna Corporation Information 12.8.2 Dicerna Description and Business Overview 12.8.3 Dicerna RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Dicerna RNA Drugs Products Offered 12.8.5 Dicerna Recent Development 12.9 Gradalis 12.9.1 Gradalis Corporation Information 12.9.2 Gradalis Description and Business Overview 12.9.3 Gradalis RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Gradalis RNA Drugs Products Offered 12.9.5 Gradalis Recent Development 12.10 Quark 12.10.1 Quark Corporation Information 12.10.2 Quark Description and Business Overview 12.10.3 Quark RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Quark RNA Drugs Products Offered 12.10.5 Quark Recent Development 12.11 Pfizer 12.11.1 Pfizer Corporation Information 12.11.2 Pfizer Description and Business Overview 12.11.3 Pfizer RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Pfizer RNA Drugs Products Offered 12.11.5 Pfizer Recent Development 12.12 Senesco 12.12.1 Senesco Corporation Information 12.12.2 Senesco Description and Business Overview 12.12.3 Senesco RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Senesco Products Offered 12.12.5 Senesco Recent Development 12.13 Silence Therapeutics 12.13.1 Silence Therapeutics Corporation Information 12.13.2 Silence Therapeutics Description and Business Overview 12.13.3 Silence Therapeutics RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Silence Therapeutics Products Offered 12.13.5 Silence Therapeutics Recent Development 12.14 Silenseed 12.14.1 Silenseed Corporation Information 12.14.2 Silenseed Description and Business Overview 12.14.3 Silenseed RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Silenseed Products Offered 12.14.5 Silenseed Recent Development 12.15 Tekmira 12.15.1 Tekmira Corporation Information 12.15.2 Tekmira Description and Business Overview 12.15.3 Tekmira RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Tekmira Products Offered 12.15.5 Tekmira Recent Development 12.16 Alnylam Pharmaceuticals 12.16.1 Alnylam Pharmaceuticals Corporation Information 12.16.2 Alnylam Pharmaceuticals Description and Business Overview 12.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Alnylam Pharmaceuticals Products Offered 12.16.5 Alnylam Pharmaceuticals Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 RNA Drugs Industry Trends 13.2 RNA Drugs Market Drivers 13.3 RNA Drugs Market Challenges 13.4 RNA Drugs Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 RNA Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global RNA Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of siRNA Table 3. Major Manufacturers of ASO Table 4. Major Manufacturers of miRNA Table 5. Major Manufacturers of Nucleic Acid Aptamers Table 6. Global RNA Drugs Market Size Growth Rate by Application (2021-2027) & (K Units) Table 7. Global RNA Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 8. Global RNA Drugs Sales by Regions (2016-2021) & (K Units) Table 9. Global RNA Drugs Sales Market Share by Regions (2016-2021) Table 10. Global RNA Drugs Revenue by Regions (2016-2021) & (US$ Million) Table 11. Global RNA Drugs Sales Forecast by Region (2022-2027) & (K Units) Table 12. Global RNA Drugs Sales Market Share Forecast by Region (2022-2027) Table 13. Global RNA Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 14. Global RNA Drugs Revenue Market Share Forecast by Region (2022-2027) Table 15. Global RNA Drugs Sales by Manufacturers (2016-2021) (K Units) Table 16. Global RNA Drugs Sales Share by Manufacturers (2016-2021) Table 17. Ranking of Global Top RNA Drugs Manufacturers by Revenue (US$ Million) in 2020 Table 18. RNA Drugs Revenue by Manufacturers (2016-2021) (US$ Million) Table 19. RNA Drugs Revenue Share by Manufacturers (2016-2021) Table 20. Global RNA Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 21. Global RNA Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Drugs as of 2020) Table 22. Key Manufacturers RNA Drugs Price (2016-2021) (USD/Unit) Table 23. RNA Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers RNA Drugs Product Type Table 25. Date of International Manufacturers Enter into RNA Drugs Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global RNA Drugs Sales by Type (2016-2021) (K Units) Table 28. Global RNA Drugs Sales Share by Type (2016-2021) Table 29. Global RNA Drugs Revenue by Type (2016-2021) (US$ Million) Table 30. Global RNA Drugs Revenue Share by Type (2016-2021) Table 31. RNA Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Table 32. Global RNA Drugs Sales Forecast by Type (2022-2027) & (K Units) Table 33. Global RNA Drugs Sales Market Share Forecast by Type (2022-2027) Table 34. Global RNA Drugs Revenue Forecast V (2022-2027) & (US$ Million) Table 35. Global RNA Drugs Revenue Market Share Forecast by Type (2022-2027) Table 36. Global RNA Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit) Table 37. Global RNA Drugs Sales by Application (2016-2021) (K Units) Table 38. Global RNA Drugs Sales Share by Application (2016-2021) Table 39. Global RNA Drugs Revenue by Application (2016-2021) (US$ Million) Table 40. Global RNA Drugs Revenue Share by Application (2016-2021) Table 41. RNA Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Table 42. Global RNA Drugs Sales Forecast by Application (2022-2027) & (K Units) Table 43. Global RNA Drugs Sales Market Share Forecast by Application (2022-2027) Table 44. Global RNA Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 45. Global RNA Drugs Revenue Market Share Forecast by Application (2022-2027) Table 46. Global RNA Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit) Table 47. United States RNA Drugs Sales (K Units) of Key Companies (2016-2021) Table 48. United States RNA Drugs Sales Share by Company (2016-2021) Table 49. United States RNA Drugs Revenue (US$ Million) by Company (2016-2021) Table 50. United States RNA Drugs Revenue Share by Company (2016-2021) Table 51. United States RNA Drugs Sales (K Units) by Type (2016-2021) Table 52. United States RNA Drugs Sales Share by Type (2016-2021) Table 53. United States RNA Drugs Revenue (US$ Million) Market Share by Type (2016-2021) Table 54. United States RNA Drugs Price (USD/Unit) by Type (2016-2021) Table 55. United States RNA Drugs Sales (K Units) by Type (2022-2027) Table 56. United States RNA Drugs Sales Share by Type (2022-2027) Table 57. United States RNA Drugs Revenue (US$ Million) Market Share by Type (2022-2027) Table 58. United States RNA Drugs Revenue Share by Type (2022-2027) Table 59. United States RNA Drugs Price (USD/Unit) by Type (2022-2027) Table 60. United States RNA Drugs Sales (K Units) by Application (2016-2021) Table 61. United States RNA Drugs Sales Share by Application (2016-2021) Table 62. United States RNA Drugs Revenue (US$ Million) Market Share by Application (2016-2021) Table 63. United States RNA Drugs Price (USD/Unit) by Application (2016-2021) Table 64. United States RNA Drugs Sales (K Units) by Application (2022-2027) Table 65. United States RNA Drugs Sales Share by Application (2022-2027) Table 66. United States RNA Drugs Revenue (US$ Million) Market Share by Application (2022-2027) Table 67. United States RNA Drugs Revenue Share by Application (2022-2027) Table 68. United States RNA Drugs Price (USD/Unit) by Application (2022-2027) Table 69. North America RNA Drugs Sales by Country (2016-2021) & (K Units) Table 70. North America RNA Drugs Sales Market Share by Country (2016-2021) Table 71. North America RNA Drugs Revenue by Country (2016-2021) & (US$ Million) Table 72. North America RNA Drugs Revenue Market Share by Country (2016-2021) Table 73. Asia Pacific RNA Drugs Sales by Region (2016-2021) & (K Units) Table 74. Asia Pacific RNA Drugs Sales Market Share by Region (2016-2021) Table 75. Asia Pacific RNA Drugs Revenue by Region (2016-2021) & (US$ Million) Table 76. Asia Pacific RNA Drugs Revenue Market Share by Region (2016-2021) Table 77. Europe RNA Drugs Sales by Country (2016-2021) & (K Units) Table 78. Europe RNA Drugs Sales Market Share by Country (2016-2021) Table 79. Europe RNA Drugs Revenue by Country (2016-2021) & (US$ Million) Table 80. Europe RNA Drugs Revenue Market Share by Country (2016-2021) Table 81. Latin America RNA Drugs Sales by Country (2016-2021) & (K Units) Table 82. Latin America RNA Drugs Sales Market Share by Country (2016-2021) Table 83. Latin Americaa RNA Drugs Revenue by Country (2016-2021) & (US$ Million) Table 84. Latin America RNA Drugs Revenue Market Share by Country (2016-2021) Table 85. Middle East and Africa RNA Drugs Sales by Country (2016-2021) & (K Units) Table 86. Middle East and Africa RNA Drugs Sales Market Share by Country (2016-2021) Table 87. Middle East and Africa RNA Drugs Revenue by Country (2016-2021) & (US$ Million) Table 88. Middle East and Africa RNA Drugs Revenue Market Share by Country (2016-2021) Table 89. Pfizer Corporation Information Table 90. Pfizer Description and Business Overview Table 91. Pfizer RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 92. Pfizer RNA Drugs Product Table 93. Pfizer Recent Development Table 94. Roche Corporation Information Table 95. Roche Description and Business Overview Table 96. Roche RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 97. Roche Product Table 98. Roche Recent Development Table 99. Sanofi-Aventis Corporation Information Table 100. Sanofi-Aventis Description and Business Overview Table 101. Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 102. Sanofi-Aventis Product Table 103. Sanofi-Aventis Recent Development Table 104. Abbott Laboratories Corporation Information Table 105. Abbott Laboratories Description and Business Overview Table 106. Abbott Laboratories RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 107. Abbott Laboratories Product Table 108. Abbott Laboratories Recent Development Table 109. Arrowhead Pharmaceuticals Corporation Information Table 110. Arrowhead Pharmaceuticals Description and Business Overview Table 111. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 112. Arrowhead Pharmaceuticals Product Table 113. Arrowhead Pharmaceuticals Recent Development Table 114. Benitec Biopharma Corporation Information Table 115. Benitec Biopharma Description and Business Overview Table 116. Benitec Biopharma RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 117. Benitec Biopharma Product Table 118. Benitec Biopharma Recent Development Table 119. Calimmune Inc Corporation Information Table 120. Calimmune Inc Description and Business Overview Table 121. Calimmune Inc RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 122. Calimmune Inc Product Table 123. Calimmune Inc Recent Development Table 124. Dicerna Corporation Information Table 125. Dicerna Description and Business Overview Table 126. Dicerna RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 127. Dicerna Product Table 128. Dicerna Recent Development Table 129. Gradalis Corporation Information Table 130. Gradalis Description and Business Overview Table 131. Gradalis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 132. Gradalis Product Table 133. Gradalis Recent Development Table 134. Quark Corporation Information Table 135. Quark Description and Business Overview Table 136. Quark RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 137. Quark Product Table 138. Quark Recent Development Table 139. RXi Corporation Information Table 140. RXi Description and Business Overview Table 141. RXi RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 142. RXi Product Table 143. RXi Recent Development Table 144. Senesco Corporation Information Table 145. Senesco Description and Business Overview Table 146. Senesco RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 147. Senesco Product Table 148. Senesco Recent Development Table 149. Silence Therapeutics Corporation Information Table 150. Silence Therapeutics Description and Business Overview Table 151. Silence Therapeutics RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 152. Silence Therapeutics Product Table 153. Silence Therapeutics Recent Development Table 154. Silenseed Corporation Information Table 155. Silenseed Description and Business Overview Table 156. Silenseed RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 157. Silenseed Product Table 158. Silenseed Recent Development Table 159. Tekmira Corporation Information Table 160. Tekmira Description and Business Overview Table 161. Tekmira RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 162. Tekmira Product Table 163. Tekmira Recent Development Table 164. Alnylam Pharmaceuticals Corporation Information Table 165. Alnylam Pharmaceuticals Description and Business Overview Table 166. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 167. Alnylam Pharmaceuticals Product Table 168. Alnylam Pharmaceuticals Recent Development Table 169. RNA Drugs Market Trends Table 170. RNA Drugs Market Drivers Table 171. RNA Drugs Market Challenges Table 172. RNA Drugs Market Restraints Table 173. RNA Drugs Customers List Table 174. RNA Drugs Distributors List Table 175. Research Programs/Design for This Report Table 176. Key Data Information from Secondary Sources Table 177. Key Data Information from Primary Sources List of Figures Figure 1. RNA Drugs Product Picture Figure 2. Global RNA Drugs Sales Market Share by Type in 2020 & 2027 Figure 3. siRNA Product Picture Figure 4. ASO Product Picture Figure 5. miRNA Product Picture Figure 6. Nucleic Acid Aptamers Product Picture Figure 7. Global RNA Drugs Sales Market Share by Application in 2020 & 2027 Figure 8. Cancer Figure 9. Diabetes Figure 10. Tuberculosis Figure 11. Cardiovascular Diseases Figure 12. Others Figure 13. RNA Drugs Report Years Considered Figure 14. Global RNA Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global RNA Drugs Market Size 2016-2027 (US$ Million) Figure 16. Global RNA Drugs Sales 2016-2027 (K Units) Figure 17. Global RNA Drugs Market Size Market Share by Region: 2021 Versus 2027 Figure 18. Global RNA Drugs Sales Market Share by Region (2016-2021) Figure 19. Global RNA Drugs Sales Market Share by Region in 2020 Figure 20. Global RNA Drugs Revenue Market Share by Region (2016-2021) Figure 21. Global RNA Drugs Revenue Market Share by Region in 2020 Figure 22. Global RNA Drugs Sales Share by Manufacturer in 2020 Figure 23. The Top 10 and 5 Players Market Share by RNA Drugs Revenue in 2020 Figure 24. RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 25. Global RNA Drugs Sales Market Share by Type (2016-2021) Figure 26. Global RNA Drugs Sales Market Share by Type in 2020 Figure 27. Global RNA Drugs Revenue Market Share by Type (2016-2021) Figure 28. Global RNA Drugs Revenue Market Share by Type in 2020 Figure 29. Global RNA Drugs Sales Market Share by Application (2016-2021) Figure 30. Global RNA Drugs Sales Market Share by Application in 2020 Figure 31. Global RNA Drugs Revenue Market Share by Application (2016-2021) Figure 32. Global RNA Drugs Revenue Market Share by Application in 2020 Figure 33. United States RNA Drugs Sales Growth Rate 2016-2027 (K Units) Figure 34. United States RNA Drugs Revenue Growth Rate 2016-2027 (US$ Million) Figure 35. United States RNA Drugs Market Share in Global Market 2016-2027 Figure 36. United States 5 and 10 Largest RNA Drugs Players Market Share by Revenue in RNA Drugs in 2020 Figure 37. United States RNA Drugs Revenue Share by Type (2016-2021) Figure 38. United States RNA Drugs Revenue Growth Rate by Type in 2016 & 2020 Figure 39. United States RNA Drugs Revenue Share by Application (2016-2021) Figure 40. United States RNA Drugs Revenue Growth Rate by Application in 2016 & 2020 Figure 41. North America RNA Drugs Sales Growth Rate 2016-2021 (K Units) Figure 42. North America RNA Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 43. North America RNA Drugs Sales Market Share by Country in 2020 Figure 44. North America RNA Drugs Revenue Market Share by Country in 2020 Figure 45. U.S. RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 46. U.S. RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Canada RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 48. Canada RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Europe RNA Drugs Sales Growth Rate 2016-2021 (K Units) Figure 50. Europe RNA Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 51. Europe RNA Drugs Sales Market Share by Country in 2020 Figure 52. Europe RNA Drugs Revenue Market Share by Country in 2020 Figure 53. Germany RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 54. Germany RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. France RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 56. France RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. U.K. RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 58. U.K. RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Italy RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 60. Italy RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Russia RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 62. Russia RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 63. Asia Pacific RNA Drugs Sales Growth Rate 2016-2021 (K Units) Figure 64. Asia Pacific RNA Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 65. Asia Pacific RNA Drugs Sales Market Share by Region in 2020 Figure 66. Asia Pacific RNA Drugs Revenue Market Share by Region in 2020 Figure 67. China RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 68. China RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. Japan RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 70. Japan RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. South Korea RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 72. South Korea RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. India RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 74. India RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Australia RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 76. Australia RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Taiwan RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 78. Taiwan RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Indonesia RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 80. Indonesia RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Thailand RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 82. Thailand RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Malaysia RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 84. Malaysia RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Philippines RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 86. Philippines RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Vietnam RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 88. Vietnam RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 89. Latin America RNA Drugs Sales Growth Rate 2016-2021 (K Units) Figure 90. Latin America RNA Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 91. Latin America RNA Drugs Sales Market Share by Country in 2020 Figure 92. Latin America RNA Drugs Revenue Market Share by Country in 2020 Figure 93. Mexico RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 94. Mexico RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Brazil RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 96. Brazil RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Argentina RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 98. Argentina RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 99. Middle East and Africa RNA Drugs Sales Growth Rate 2016-2021 (K Units) Figure 100. Middle East and Africa RNA Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 101. Middle East and Africa RNA Drugs Sales Market Share by Country in 2020 Figure 102. Middle East and Africa RNA Drugs Revenue Market Share by Country in 2020 Figure 103. Turkey RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 104. Turkey RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Saudi Arabia RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 106. Saudi Arabia RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. U.A.E RNA Drugs Sales Growth Rate (2016-2021) (K Units) Figure 108. U.A.E RNA Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 109. RNA Drugs Value Chain Figure 110. Channels of Distribution Figure 111. Distributors Profiles Figure 112. Bottom-up and Top-down Approaches for This Report Figure 113. Data Triangulation Figure 114. Key Executives Interviewed

Pfizer Roche Sanofi-Aventis Abbott Laboratories Arrowhead Pharmaceuticals Benitec Biopharma Calimmune Inc Dicerna Gradalis Quark RXi Senesco Silence Therapeutics Silenseed Tekmira Alnylam Pharmaceuticals